Literature DB >> 3504406

Effects of flunarizine on Metrazol-induced seizures in developing rats.

M Pohl1, P Mares.   

Abstract

Antimetrazol action of flunarizine (5, 10, 20 and 40 mg/kg i.p.) was tested during ontogenesis on male Wistar rats aged 7, 12, 18, 25 and 90 days. The latencies and incidences of jerks, minimal Metrazol seizures and major Metrazol seizures remained unchanged by flunarizine in all age groups. A specific action (an abolition of the tonic phase of major seizures) was seen throughout the development and was reflected in lower scores of seizures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3504406     DOI: 10.1016/0920-1211(87)90006-4

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  9 in total

1.  Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.

Authors:  Nicholas A Jones; Andrew J Hill; Imogen Smith; Sarah A Bevan; Claire M Williams; Benjamin J Whalley; Gary J Stephens
Journal:  J Pharmacol Exp Ther       Date:  2009-11-11       Impact factor: 4.030

2.  Pentylenetetrazol-induced seizures in rats: an ontogenetic study.

Authors:  L Velisek; H Kubova; M Pohl; L Stankova; P Mares; R Schickerova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

3.  Effects of genistein on pentylenetetrazole-induced behavioral and neurochemical deficits in ovariectomized rats.

Authors:  Amr A Elsayed; Esther T Menze; Mariane G Tadros; Bassant M M Ibrahim; Nagwa A Sabri; Amani E Khalifa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-10-25       Impact factor: 3.000

4.  Convulsant action of a benzodiazepine receptor agonist/inverse agonist Ro 19-4603 in developing rats.

Authors:  H Kubová; P Mares
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

5.  Pentylenetetrazole-induced seizures in developing rats prenatally exposed to valproic acid.

Authors:  Angel A Puig-Lagunes; Jorge Manzo; Luis Beltrán-Parrazal; Consuelo Morgado-Valle; Rebeca Toledo-Cárdenas; Maria-Leonor López-Meraz
Journal:  PeerJ       Date:  2016-11-29       Impact factor: 2.984

6.  Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats.

Authors:  Libor Uttl; Tomáš Hložek; Pavel Mareš; Tomáš Páleníček; Hana Kubová
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

7.  Anticonvulsant Action of GluN2A-Preferring Antagonist PEAQX in Developing Rats.

Authors:  Pavel Mares; Grygoriy Tsenov; Hana Kubova
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

8.  BICS01 Mediates Reversible Anti-seizure Effects in Brain Slice Models of Epilepsy.

Authors:  Gareth Morris; Mona Heiland; Kai Lamottke; Haifeng Guan; Thomas D M Hill; Yijun Zhou; Qianjin Zhu; Stephanie Schorge; David C Henshall
Journal:  Front Neurol       Date:  2022-01-06       Impact factor: 4.003

9.  The Neuroactive Steroid Pregnanolone Glutamate: Anticonvulsant Effect, Metabolites and Its Effect on Neurosteroid Levels in Developing Rat Brains.

Authors:  Eva Kudova; Pavel Mares; Martin Hill; Katerina Vondrakova; Grygoriy Tsenov; Hana Chodounska; Hana Kubova; Karel Vales
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.